SWOG clinical trial number
SWOG-9511

A Phase II Study of Trimetrexate, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach

Closed
Phase
Accrual
100%
Published
Abbreviated Title
A Phase II Study of Trimetrexate, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach
Activated
01/15/1997
Closed
11/15/1998

Publication Information Expand/Collapse

2010

S9511: a Southwest Oncology Group phase II study of trimetrexate, 5FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach

CD Blanke;K Chansky;KL Christman;SA Hundahl;BF Issell;PJ Van Veldhuizen Jr;GT Budd;JL Abbruzzese;JS Macdonald American Journal of Clinical Oncology, Apr; 33(2):117-120;

PMid: PMID19770625 | PMC number: PMC2967385